Ligang Nan

463 total citations
7 papers, 386 citations indexed

About

Ligang Nan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ligang Nan has authored 7 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Ligang Nan's work include Cancer, Hypoxia, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Ligang Nan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Ligang Nan collaborates with scholars based in China and United States. Ligang Nan's co-authors include Xuqi Li, Zhengdong Jiang, Qingyong Ma, Wanxing Duan, Jianjun Lei, Qinhong Xu, Zheng Wang, Jiguang Ma, Ke Chen and Zhenhua Ma and has published in prestigious journals such as Annals of the New York Academy of Sciences, Oncotarget and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Ligang Nan

7 papers receiving 384 citations

Peers

Ligang Nan

MB

ONCOL

CR

CAM

EPIDE

Shumei Ma China

Subrata K. Pore United States

Minghua Li China

Deblina Guha India

Fangfang Gao China

Hyereen Kang South Korea

Valentin David France

Guangping Lu China

Shuhua Wu China

Yun-Ching Chang Taiwan

Shumei Ma China

Ligang Nan

232 ×1.2

MB

47 ×0.4

ONCOL

122 ×1.0

CR

17 ×0.4

CAM

44 ×1.1

EPIDE

Citations per year, relative to Ligang Nan Ligang Nan (= 1×) peers Shumei Ma

Countries citing papers authored by Ligang Nan

Since Specialization

Citations

This map shows the geographic impact of Ligang Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ligang Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ligang Nan more than expected).

Fields of papers citing papers by Ligang Nan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ligang Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ligang Nan. The network helps show where Ligang Nan may publish in the future.

Co-authorship network of co-authors of Ligang Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Ligang Nan. A scholar is included among the top collaborators of Ligang Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ligang Nan. Ligang Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Nan, Ligang, Tao Qin, Ying Xiao, et al.. (2019). Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway. Cell Transplantation. 28(9-10). 1289–1298. 36 indexed citations

2.

Zhang, Lun, Jiahui Li, Liang Zong, et al.. (2016). Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. Oxidative Medicine and Cellular Longevity. 2016(1). 99 indexed citations

3.

Duan, Wanxing, Rong Li, Jiguang Ma, et al.. (2015). Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway. Oncotarget. 6(3). 1490–1506. 34 indexed citations

4.

Xu, Qinhong, Pei Li, Xin Chen, et al.. (2015). miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases. Oncotarget. 6(16). 14153–14164. 71 indexed citations

5.

Ma, Jiguang, Wanxing Duan, Suxia Han, et al.. (2015). Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis. Oncotarget. 6(25). 20993–21003. 74 indexed citations

6.

Zhang, Dong, Jianjun Lei, Jiguang Ma, et al.. (2015). β2-Adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α. Oncotarget. 7(14). 17760–17772. 14 indexed citations

7.

Xu, Qinhong, Liang Zong, Xin Chen, et al.. (2015). Resveratrol in the treatment of pancreatic cancer. Annals of the New York Academy of Sciences. 1348(1). 10–19. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact